Health
International trial shows better option for treating people with inoperable anal cancer – News-Medical.Net
People with inoperable anal cancer treated with carboplatin-paclitaxel had fewer complications and lived longer than those who received another chemotherapy that has been more often administered.
Reviewed by Emily Henderson, B.Sc.Jun 24 2020
People with inoperable anal cancer treated with carboplatin-paclitaxel had fewer complications and lived longer than those who received another chemothe…
Continue Reading